Patient Feedback Spurs Expansion of ADDRESS-LC Trial: More Test Sites, Broader Enrollment
In July, Solve hosted a webinar featuring representatives of the ADDRESS-LC Trial, which was designed to assess the potential impact of the drug bezisterim on cognitive impairment/brain fog and fatigue […]
Watch! The ADDRESS-LC Trial Webinar
The ADDRESS-LC trial was designed to assess the potential impact of bezisterim on cognitive impairment/brain fog and fatigue in individuals with Long Covid and is currently recruiting people aged 18-64 […]
The ADDRESS-LC Trial: Studying the Impact of Bezisterim on Brain fog and Fatigue in People with Long Covid
In this webinar, we’ll be joined by panelists Michael Peluso, MD (Assistant Professor of Medicine, University of California, San Francisco) Ezra Spier (Creator, Long Covid Studies), Penelope Markham, PhD (Senior […]
Exploring Current ME/CFS and Long COVID Clinical Trials on National Clinical Trials Day
May 20 is National Clinical Trials Day! When conducting clinical trials, researchers test how interventions (like behavioral changes, drugs, or medical devices) affect people. Usually, researchers carefully choose who takes […]
Solve Advocacy Efforts Yield Another Victory!
Solve Advocacy Efforts Yield Another Victory! CDMRP Program at Department of Defense Announces $13.1M Grant for Long Covid Research Solve is dedicated to opening new funding avenues for ME/CFS, Long Covid, […]